A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma
Titel:
A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma
Auteur:
Mayer, E.L. DeMichele, A. Rugo, H.S. Miller, K. Waks, A.G. Come, S.E. Mulvey, T. Jeselsohn, R. Overmoyer, B. Guo, H. Barry, W.T. Huang Bartlett, C. Koehler, M. Winer, E.P. Burstein, H.J.